よむ、つかう、まなぶ。
【参考資料4】抗微生物薬適正使用の手引き 第三版 本編 (104 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
| 出典情報 | 厚生科学審議会 感染症部会 薬剤耐性（AMR）に関する小委員会 抗微生物薬適正使用（AMS）等に関する作業部会（第6回 11／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第三版
100. Szajewska H, et al. Working Group on Probiotics and Prebiotics of the European Society for
Paediatric Gastroenterology, Hepatology and Nutrition. Use of Probiotics for the
Management of Acute Gastroenteritis in Children: An Update. J Pediatr Gastroenterol Nutr.
2020 Aug;71(2):261-269.
101. JaA. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. McGraw-Hill
Education, LLC; 2009.
102. Tajiri H, et al. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic
syndrome accompanying Shiga toxin-producing Escherichia coli infection. Int J Antimicrob
Agents. 2015 Nov;46(5):586-9.
103. Myojin S, et al. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and
risk of hemolytic uremic syndrome: A population-based matched case control study. PLoS
One. 2022 Feb 4;17(2):e0263349.
104. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Effect of early fosfomycin
treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli
O157:H7 infection. Clinical nephrology 1999;52:357-62.
105. 日本耳科学会／日本小児耳鼻咽喉科学会／日本耳鼻咽喉科感染症・エアロゾル学会. 小児急
性中耳炎診療ガイドライン 2018 年版. 金原出版; 2018
106. 日本耳科学会／日本小児耳鼻咽喉科学会. 小児滲出性中耳炎診療ガイドライン 2015 年版. 金
原出版; 2015
107. Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr Infect Dis J. 1998;17:110513
108. Kerschner JE, Preciado D. Otitis media. In: Kliegman RM, Stanton BF, St. Geme JW, Schor
NF, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:chap 640
p3085
109. Todberg T, Koch A, Andersson M, Olsen SF, Lous J, Homoe P (2014) Incidence of Otitis
Media in a Contemporary Danish National Birth Cohort. PLoS ONE 9(12)
110. Hotomi M, Yamanaka N, Saito T, Shimada J, Suzumoto M, Suetake M, Faden H. Antibody
responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and
pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol.
1999;119(6):703-7.
111. Yamanaka N, Faden H: Antibody response to outer membrane protein of nontypeable
Haemophilus influenzae in otitis-prone children. J Pediatr 1993;122:212-8.
112. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD,
Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE. The diagnosis
and management of acute otitis media. Pediatrics. 2013 Mar;131(3):e964-99
113. 佐伯忠彦；愛媛医学 13 巻 1 号 26-33, 1994.
114. Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr
Adolesc Med. 1995 Jan;149(1):26-9.
115. Uhari M, Niemelä M, Hietala J. Prediction of acute otitis media with symptoms and signs.
Acta Paediatr 1995;84(1):90-2.
104
第三版
100. Szajewska H, et al. Working Group on Probiotics and Prebiotics of the European Society for
Paediatric Gastroenterology, Hepatology and Nutrition. Use of Probiotics for the
Management of Acute Gastroenteritis in Children: An Update. J Pediatr Gastroenterol Nutr.
2020 Aug;71(2):261-269.
101. JaA. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. McGraw-Hill
Education, LLC; 2009.
102. Tajiri H, et al. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic
syndrome accompanying Shiga toxin-producing Escherichia coli infection. Int J Antimicrob
Agents. 2015 Nov;46(5):586-9.
103. Myojin S, et al. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and
risk of hemolytic uremic syndrome: A population-based matched case control study. PLoS
One. 2022 Feb 4;17(2):e0263349.
104. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Effect of early fosfomycin
treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli
O157:H7 infection. Clinical nephrology 1999;52:357-62.
105. 日本耳科学会／日本小児耳鼻咽喉科学会／日本耳鼻咽喉科感染症・エアロゾル学会. 小児急
性中耳炎診療ガイドライン 2018 年版. 金原出版; 2018
106. 日本耳科学会／日本小児耳鼻咽喉科学会. 小児滲出性中耳炎診療ガイドライン 2015 年版. 金
原出版; 2015
107. Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr Infect Dis J. 1998;17:110513
108. Kerschner JE, Preciado D. Otitis media. In: Kliegman RM, Stanton BF, St. Geme JW, Schor
NF, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:chap 640
p3085
109. Todberg T, Koch A, Andersson M, Olsen SF, Lous J, Homoe P (2014) Incidence of Otitis
Media in a Contemporary Danish National Birth Cohort. PLoS ONE 9(12)
110. Hotomi M, Yamanaka N, Saito T, Shimada J, Suzumoto M, Suetake M, Faden H. Antibody
responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and
pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol.
1999;119(6):703-7.
111. Yamanaka N, Faden H: Antibody response to outer membrane protein of nontypeable
Haemophilus influenzae in otitis-prone children. J Pediatr 1993;122:212-8.
112. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD,
Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE. The diagnosis
and management of acute otitis media. Pediatrics. 2013 Mar;131(3):e964-99
113. 佐伯忠彦；愛媛医学 13 巻 1 号 26-33, 1994.
114. Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr
Adolesc Med. 1995 Jan;149(1):26-9.
115. Uhari M, Niemelä M, Hietala J. Prediction of acute otitis media with symptoms and signs.
Acta Paediatr 1995;84(1):90-2.
104